Biology Reference
In-Depth Information
in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/
FGFR-2 pathway. J Biol Chem 284(38):25854-25866
Armstrong PB, Quigley JP, Sidebottom E (1982) Transepithelial invasion and intramesenchymal
infiltration of the chick embryo chorioallantois by tumor cell lines. Cancer Res 42(5):
1826-1837
Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC (2006) Dynamic inter-
actions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining
the stages of invadopodia formation and function. Cancer Res 66(6):3034-3043
Auersperg N, Pan J, Grove BD, Peterson T, Fisher J, Maines-Bandiera S, Somasiri A,
Roskelley CD (1999) E-cadherin induces mesenchymal-to-epithelial transition in human
ovarian surface epithelium. Proc Natl Acad Sci USA 96(11):6249-6254
Balkwill F, Charles KA, Mantovani A (2005) Smoldering and polarized inflammation in the
initiation and promotion of malignant disease. Cancer Cell 7(3):211-217
Bendrik C, Robertson J, Gauldie J, Dabrosin C (2008) Gene transfer of matrix metalloproteinase-9
induces tumor regression of breast cancer in vivo. Cancer Res 68(9):3405-3412
Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer
3(6):401-410
Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S,
Werb Z, Hanahan D (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during
carcinogenesis. Nat Cell Biol 2(10):737-744
Bhowmick NA, Neilson EG, Moses HL (2004) Stromal fibroblasts in cancer initiation and
progression. Nature 432(7015):332-337
Billottet C, Tuefferd M, Gentien D, Rapinat A, Thiery JP, Broet P, Jouanneau J (2008) Modulation
of several waves of gene expression during FGF-1 induced epithelial-mesenchymal transition
of carcinoma cells. J Cell Biochem 104(3):826-839
Bjorklund M, Heikkila P, Koivunen E (2004) Peptide inhibition of catalytic and noncatalytic
activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion. J Biol Chem
279(28):29589-29597
Blackburn JS, Liu I, Coon CI, Brinckerhoff CE (2009) A matrix metalloproteinase-1/protease
activated receptor-1 signaling axis promotes melanoma invasion and metastasis. Oncogene
28(48):4237-4248
Bockhorn M, Jain RK, Munn LL (2007) Active versus passive mechanisms in metastasis: do
cancer cells crawl into vessels, or are they pushed? Lancet Oncol 8(5):444-448
Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A (2005) PAR1 is a matrix
metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.
Cell 120(3):303-313
Borrirukwanit K, Lafleur MA, Mercuri FA, Blick T, Price JT, Fridman R, Pereira JJ, Leardka-
monkarn V, Thompson EW (2007) The type I collagen induction of MT1-MMP-mediated
MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells. Matrix
Biol 26(4):291-305
Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, Minn AJ, van de Vijver MJ, Gerald
WL, Foekens JA, Massague J (2009) Genes that mediate breast cancer metastasis to the brain.
Nature 459(7249):1005-1009
Bourguignon LY, Gunja-Smith Z, Iida N, Zhu HB, Young LJ, Muller WJ, Cardiff RD (1998) CD44v
(3, 8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloprotei-
nase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol 176(1):206-215
Brandt B, Heyder C, Gloria-Maercker E, Hatzmann W, Rotger A, Kemming D, Zanker KS,
Entschladen F, Dittmar T (2005) 3D-extravasation model - selection of highly motile and
metastatic cancer cells. Semin Cancer Biol 15(5):387-395
Brooks PC, Silletti S, von Schalscha TL, Friedlander M, Cheresh DA (1998) Disruption of
angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity.
Cell 92(3):391-400
